Default credentials are used in the above listed BD Diagnostic Solutions products. If exploited, threat actors may be able to access, modify or delete data, including sensitive information such as protected health information (PHI) and personally identifiable information (PII). Exploitation of this vulnerability may allow an attacker to shut down or otherwise impact the availability of the system. Note: BD Synapsys™ Informatics Solution is only in scope of this vulnerability when installed on a NUC server. BD Synapsys™ Informatics Solution installed on a customer-provided virtual machine or on the BD Kiestra™ SCU hardware is not in scope.

The FACSChorus software does not properly assign data access privileges for operating system user accounts. A non-administrative OS account can modify information stored in the local application data folders.

The FACSChorus software database can be accessed directly with the privileges of the currently logged-in user. A threat actor with physical access could potentially gain credentials, which could be used to alter or destroy data stored in the database.

The FACSChorus software contains sensitive information stored in plaintext. A threat actor could gain hardcoded secrets used by the application, which include tokens and passwords for administrative accounts.

The FACSChorus workstation does not prevent physical access to its PCI express (PCIe) slots, which could allow a threat actor to insert a PCI card designed for memory capture. A threat actor can then isolate sensitive information such as a BitLocker encryption key from a dump of the workstation RAM during startup.

The Operating System hosting the FACSChorus application is configured to allow transmission of hashed user credentials upon user action without adequately validating the identity of the requested resource. This is possible through the use of LLMNR, MBT-NS, or MDNS and will result in NTLMv2 hashes being sent to a malicious entity position on the local network. These hashes can subsequently be attacked through brute force and cracked if a weak password is used. This attack would only apply to domain joined systems.

There is no BIOS password on the FACSChorus workstation. A threat actor with physical access to the workstation can potentially exploit this vulnerability to access the BIOS configuration and modify the drive boot order and BIOS pre-boot authentication.

The FACSChorus workstation operating system does not restrict what devices can interact with its USB ports. If exploited, a threat actor with physical access to the workstation could gain access to system information and potentially exfiltrate data.

An insecure connection between Systems Manager and CQI Reporter application could expose infusion data to an attacker.

Alaris Systems Manager does not perform input validation during the Device Import Function.

A malicious file could be uploaded into a System Manager User Import Function resulting in a hijacked session.

A GRE dataset file within Systems Manager can be tampered with and distributed to PCUs.

The data flowing between the PCU and its modules is insecure. A threat actor with physical access could potentially read or modify data by attaching a specially crafted device while an infusion is running.

The configuration from the PCU can be modified without authentication using physical connection to the PCU.

The configuration from the PCU can be modified without authentication using physical connection to the PCU.

The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installations may choose to store personal data.

The BD BodyGuard™ infusion pumps specified allow for access through the RS-232 (serial) port interface. If exploited, threat actors with physical access, specialized equipment and knowledge may be able to configure or disable the pump. No electronic protected health information (ePHI), protected health information (PHI) or personally identifiable information (PII) is stored in the pump.

BD Totalys MultiProcessor, versions 1.70 and earlier, contain hardcoded credentials. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII). Customers using BD Totalys MultiProcessor version 1.70 with Microsoft Windows 10 have additional operating system hardening configurations which increase the attack complexity required to exploit this vulnerability.

BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).

Specific BD Pyxis™ products were installed with default credentials and may presently still operate with these credentials. There may be scenarios where BD Pyxis™ products are installed with the same default local operating system credentials or domain-joined server(s) credentials that may be shared across product types. If exploited, threat actors may be able to gain privileged access to the underlying file system and could potentially exploit or gain access to ePHI or other sensitive information.

BD Viper LT system, versions 2.0 and later, contains hardcoded credentials. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII). BD Viper LT system versions 4.0 and later utilize Microsoft Windows 10 and have additional Operating System hardening configurations which increase the attack complexity required to exploit this vulnerability.

Hardcoded credentials are used in specific BD Pyxis products. If exploited, threat actors may be able to gain access to the underlying file system and could potentially exploit application files for information that could be used to decrypt application credentials or gain access to electronic protected health information (ePHI) or other sensitive information.

BD Alaris PC Unit, Model 8015, Versions 9.33.1 and earlier and BD Alaris Systems Manager, Versions 4.33 and earlier The affected products are vulnerable to a network session authentication vulnerability within the authentication process between specified versions of the BD Alaris PC Unit and the BD Alaris Systems Manager. If exploited, an attacker could perform a denial-of-service attack on the BD Alaris PC Unit by modifying the configuration headers of data in transit. A denial-of-service attack could lead to a drop in the wireless capability of the BD Alaris PC Unit, resulting in manual operation of the PC Unit.

In BD Pyxis MedStation ES System v1.6.1 and Pyxis Anesthesia (PAS) ES System v1.6.1, a restricted desktop environment escape vulnerability exists in the kiosk mode functionality of affected devices. Specially crafted inputs could allow the user to escape the restricted environment, resulting in access to sensitive data.

In Pyxis ES Versions 1.3.4 through to 1.6.1 and Pyxis Enterprise Server, with Windows Server Versions 4.4 through 4.12, a vulnerability has been identified where existing access privileges are not restricted in coordination with the expiration of access based on active directory user account changes when the device is joined to an AD domain.

BD Alaris Gateway Workstation Versions, 1.1.3 Build 10, 1.1.3 MR Build 11, 1.2 Build 15, 1.3.0 Build 14, 1.3.1 Build 13, This does not impact the latest firmware Versions 1.3.2 and 1.6.1, Additionally, the following products using software Version 2.3.6 and below, Alaris GS, Alaris GH, Alaris CC, Alaris TIVA, The application does not restrict the upload of malicious files during a firmware update.

BD Alaris Gateway versions, 1.0.13,1.1.3 Build 10,1.1.3 MR Build 11,1.1.5, and 1.1.6, The web browser user interface on the Alaris Gateway Workstation does not prevent an attacker with knowledge of the IP address of the Alaris Gateway Workstation terminal to gain access to the status and configuration information of the device.

BD FACSLyric Research Use Only, Windows 10 Professional Operating System, U.S. and Malaysian Releases, between November 2017 and November 2018 and BD FACSLyric IVD Windows 10 Professional Operating System US release does not properly enforce user access control to privileged accounts, which may allow for unauthorized access to administrative level functions.

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.

A vulnerability in ReadA version 1.1.0.2 and previous allows an authorized user with access to a privileged account on a BD Kiestra system (Kiestra TLA, Kiestra WCA, and InoqulA+ specimen processor) to issue SQL commands, which may result in loss or corruption of data.